Terms: = Kidney tumors AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP
106 results:
1. Characterization of Alternative Splicing in High-Risk Wilms' tumors.
Trink Y; Urbach A; Dekel B; Hohenstein P; Goldberger J; Kalisky T
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674106
[TBL] [Abstract] [Full Text] [Related]
2. Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
Atkins MB; Jegede OA; Haas NB; Mcdermott DF; Bilen MA; Stein M; Sosman J; Alter R; Plimack ER; Ornstein MC; Hurwitz M; Peace DJ; Einstein D; Catalano PJ; Hammers H; Regan MM
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604810
[TBL] [Abstract] [Full Text] [Related]
3. The novel CDK9 inhibitor, XPW1, alone and in combination with brd4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma.
Kuang Z; Guo K; Cao Y; Jiang M; Wang C; Wu Q; Hu G; Ao M; Huang M; Qin J; Zhao T; Lu S; Sun C; Li M; Wu T; Liu W; Fang M
Br J Cancer; 2023 Dec; 129(12):1915-1929. PubMed ID: 37884683
[TBL] [Abstract] [Full Text] [Related]
4. Greening microwave-assisted digestion method using hydrogen peroxide for determination of elemental impurities by ICP-OES in antihypertensive active pharmaceutical ingredients.
Senger CM; Dornelles IS; Queiroz JM; Mello PA; Muller EI; Muller ALH
J Pharm Biomed Anal; 2024 Jan; 238():115802. PubMed ID: 37871418
[TBL] [Abstract] [Full Text] [Related]
5. Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?
Wang M; Wittenberg S; Cher ML; Van Til M; Ferrante S; Mirza M; Johnson A; Semerjian A; George A; Rogers C; Wilder S; Sarle R; Ghani KR; Lane B; Ginsburg KB;
Eur Urol; 2024 Feb; 85(2):101-104. PubMed ID: 37507241
[TBL] [Abstract] [Full Text] [Related]
6. Sanguinarine targets brd4 to suppress cell proliferation and migration in clear cell renal cell carcinoma.
Wen Y; Song Y; Ma Y; Wen J; Yang J
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23451. PubMed ID: 37393519
[TBL] [Abstract] [Full Text] [Related]
7. An International Survey of Genitourinary and Renal Pathologists Regarding Evaluation of the Non-Neoplastic Parenchyma in kidney Cancer Specimens.
Paik J; Ellis CL; Henriksen KJ; Chang A
Int J Surg Pathol; 2024 Apr; 32(2):273-278. PubMed ID: 37226477
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of Continuous Transcriptional Heterogeneity in High-Risk Blastemal-Type Wilms' tumors Using Unsupervised Machine Learning.
Trink Y; Urbach A; Dekel B; Hohenstein P; Goldberger J; Kalisky T
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834944
[TBL] [Abstract] [Full Text] [Related]
9. BET-HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis.
Huang Y; Liu N; Pan Z; Li Z; Sheng C
J Med Chem; 2023 Jan; 66(2):1239-1253. PubMed ID: 36622852
[TBL] [Abstract] [Full Text] [Related]
10. Deregulation of SPOP in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
11. Characterization of alternative mRNA splicing in cultured cell populations representing progressive stages of human fetal kidney development.
Wineberg Y; Kanter I; Ben-Haim N; Pode-Shakked N; Bucris E; Bar-Lev TH; Oriel S; Reinus H; Yehuda Y; Gershon R; Shukrun R; Bar-Lev DD; Urbach A; Dekel B; Kalisky T
Sci Rep; 2022 Nov; 12(1):19548. PubMed ID: 36380228
[TBL] [Abstract] [Full Text] [Related]
12. BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress-related tumorigenicity.
Takemoto K; Kobatake K; Miura K; Fukushima T; Babasaki T; Miyamoto S; Sekino Y; Kitano H; Goto K; Ikeda K; Hieda K; Hayashi T; Hinata N; Kaminuma O
Cancer Sci; 2023 Feb; 114(2):436-448. PubMed ID: 36178067
[TBL] [Abstract] [Full Text] [Related]
13. Multiple primary cancers in men with sporadic or familial prostate cancer: Its clinical implications.
Kim M; Sung J; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Urol Oncol; 2022 Nov; 40(11):489.e1-489.e7. PubMed ID: 36167773
[TBL] [Abstract] [Full Text] [Related]
14. capsaicin inhibits the migration, invasion and EMT of renal cancer cells by inducing AMPK/mTOR-mediated autophagy.
Que T; Ren B; Fan Y; Liu T; Hou T; Dan W; Liu B; Wei Y; Lei Y; Zeng J; Li L
Chem Biol Interact; 2022 Oct; 366():110043. PubMed ID: 36044967
[TBL] [Abstract] [Full Text] [Related]
15. Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma.
Liu Z; Lin D; Zhou Y; Zhang L; Yang C; Guo B; Xia F; Li Y; Chen D; Wang C; Chen Z; Leng C; Xiao Z
Sci Rep; 2022 Aug; 12(1):13222. PubMed ID: 35918352
[TBL] [Abstract] [Full Text] [Related]
16. Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study.
Klein EA; Partin A; Lotan Y; Baniel J; Dineen M; Hafron J; Manickam K; Pliskin M; Wagner M; Kestranek A; Stovsky M
Urol Oncol; 2022 Sep; 40(9):408.e9-408.e18. PubMed ID: 35840465
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate.
Lone Z; Benidir T; Rainey M; Nair M; Davicioni E; Gibb EA; Williamson S; Gupta S; Chaim Ornstein M; Tendulkar R; Weight C; Nguyen JK; Klein EA; Mian OY
Eur Urol Focus; 2022 Nov; 8(6):1575-1582. PubMed ID: 35662504
[TBL] [Abstract] [Full Text] [Related]
18. Pathologic fracture in metastatic kidney cancer: Identifying widening disparities and opportunity for quality improvement.
Bhanvadia RR; Baky FJ; Ashbrook CQ; Lotan Y; Woldu SL
Urol Oncol; 2022 Aug; 40(8):384.e1-384.e8. PubMed ID: 35662499
[TBL] [Abstract] [Full Text] [Related]
19. NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity.
Xu B; Chen JF; Sarungbam J; Tickoo S; Dickson BC; Reuter VE; Antonescu CR
Genes Chromosomes Cancer; 2022 Sep; 61(9):542-550. PubMed ID: 35430756
[TBL] [Abstract] [Full Text] [Related]
20. Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
Certan M; Garcia Garrido HM; Wong G; Heijmans J; Grobusch MP; Goorhuis A
Clin Infect Dis; 2022 Sep; 75(6):1046-1053. PubMed ID: 35195716
[TBL] [Abstract] [Full Text] [Related]
[Next]
